Form 8-K - Current report:
SEC Accession No. 0001140361-24-041100
Filing Date
2024-09-16
Accepted
2024-09-16 06:46:57
Documents
18
Period of Report
2024-09-14
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20035872_8k.htm   iXBRL 8-K 32368
2 EXHIBIT 99.1 ef20035872_ex99-1.htm EX-99.1 47374
6 image00002.jpg GRAPHIC 3311
7 image00003.jpg GRAPHIC 11598
8 image00004.jpg GRAPHIC 12178
9 image00005.jpg GRAPHIC 9508
  Complete submission text file 0001140361-24-041100.txt   281488

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA imcr-20240914.xsd EX-101.SCH 3874
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE imcr-20240914_lab.xml EX-101.LAB 21966
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imcr-20240914_pre.xml EX-101.PRE 16050
21 EXTRACTED XBRL INSTANCE DOCUMENT ef20035872_8k_htm.xml XML 4442
Mailing Address 90 PARK DRIVE MILTON PARK, ABINGDON OXFORDSHIRE X0 OX14 4RY
Business Address 90 PARK DRIVE MILTON PARK, ABINGDON OXFORDSHIRE X0 OX14 4RY 01235 5430281
Immunocore Holdings plc (Filer) CIK: 0001671927 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39992 | Film No.: 241299289
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)